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e132 LettersOur case raises the awareness and recognition of
granulomatous dermatitis as a new adverse cuta-
neous reaction to VZV vaccination.
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Spurious elevation of aspartate
aminotransferase in a patient on isotretinoin
To the Editor: Approximately 11% of patients on
isotretinoin develop a mild reversible transaminitis.1
We report a case of spurious elevation of aspartate
aminotransferase (AST) during treatment for acne.
A 15-year-old male with recalcitrant nodulocystic
acne was started on isotretinoin 20 mg daily. He had
a history of Hodgkin lymphoma that was in remis-
sion for 1 year. Initial screening laboratory investi-
gation results were normal except for an elevated
AST at 61 /L (range 15-45 /L). He denied alcohol
consumption. At his 1-month follow-up visit, the AST
level was 77 /L, while other liver enzymes remainedOpen access under CC BY-NC-ND license.normal. Because we had observed this finding in
other patients at the satellite center where he was
seen, we considered whether the method of pro-
cessing the specimen might be a factor. The patient’s
blood had been drawn and centrifuged on-site,
within minutes of collection. The specimen was
packaged in a cooler and transported by courier
several miles to the central hospital laboratory for
testing. The AST value of 77 /L was obtained using a
plasma separator tube (PST), on a plasma specimen.
Using a serum separator tube (SST), a sample of
serum from the same blood draw revealed a normal
AST (29 /L). Enzyme levels remained within the
normal range for the duration of therapy while using
SSTs for testing.
Samples collected in both SSTs and PSTs are
centrifuged after collection, but while SSTs segregate
cells and platelets away from the serum, PSTs do not
isolate platelets well, leaving them in the plasma.2 If a
specimen is tested immediately after processing,
then either a PST or SST may be used. In our case,
prolonged plasma exposure to disintegrating plate-
lets in a transported PST tube was the likely cause of
the spuriously elevated AST results.2 Spurious AST
elevation can result from other collection errors,
such as improper tube selection with a light blue
anticoagulant tube, as well as from iatrogenic hemo-
lysis from using a too-small venipuncture needle.3
Elevations in serum alanine aminotransferase
(ALT) and AST result from tissue injury or increased
cell permeability, which release aminotransferases
into the circulation. ALT is a cytosolic enzyme found
predominantly in the liver, with much smaller quan-
tities in heart and skeletal muscle.4,5 AST is both a
cytosolic and a mitochondrial isoenzyme. High
concentrations ofASTare found in a variety of tissues,
including the liver, heart, skeletal muscle, and blood
components. AST elevation may result from amyriad
of causes, ranging from muscle injury to hemolysis.5
While an elevated AST level may reflect liver or
muscle injury andmerits careful evaluation, it is useful
to understand other causes of isolated AST elevation,
such as in this case, an artifact of sample collection.
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Fig 1. Bullous erythema migrans in Lyme disease
(initial presentation): 12-cm annular, erythematous patch
with a centrally located 5-cm tender, indurated bulla with
surrounding vesicles.
Fig 2. Bullous Lyme disease (2 months after treatment
with doxycycline 100 mg by mouth, twice daily for
21 days): 5-cm patch of postinflammatory hyperpigmen-
tation and hypopigmentation.
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Bullous Lyme disease
To the Editor: A 57-year-old woman living in the
Upper Connecticut River Valley presented in July
2011 with an acute blistering rash on her left
thigh that she believed was caused by a spider bite.
The lesion rapidly progressed over 4 days from a
small tender red papule to a 12-cm annular,
erythematous patch with a centrally located 5-cm
tender, indurated bulla with surrounding vesicles
(Fig 1). She also reported mild fever, headache,
nausea, and arthralgia. She denied a history of a
recent tick bite, hiking, or recent travel, but she did
live in a wooded, rural area with numerous deer,
frequently used a riding lawn mower, and stated she
often saw ticks on her property.
The patient was seen by her primary care provider
and in the emergency department before presenting
to dermatology. Because of the bullous nature of the
eruption, the differential diagnosis included bite
reaction, cellulitis, herpes simplex, herpes zoster,
and Lyme disease. Initial workup included
complete blood cell count, basic metabolic panel,
blood cultures, bacterial and herpes simplex/
varicella-zoster virus cultures of the vesicular
fluid, herpes simplex/varicella-zoster virus rapid
stain, and Lyme IgG and IgM antibodies. All revealed
normal findings. Given our confidence this was
acute Lyme disease, we decided to treat the patient
with doxycycline (100 mg by mouth, twice daily for
21 days). The rash and systemic symptoms rapidly
resolved (Fig 2). Repeated Lyme antibody titers
drawn 8 weeks later were positive for IgM by
Western blot.
The first stage of Lyme disease usually features
erythema migrans at the site of inoculation,
accompanied by a flulike illness with nonspecific
symptoms of fatigue, myalgia, headache, and
fever. Of patients, 60% to 90% present with the
classic erythema migrans rash, described as anerythematous macule that spreads centrifugally and
may develop central clearing.1 Atypical presenta-
tions have been reported, including hemorrhagic
and necrotic cutaneous changes.2,3 Vesicular or
bullous variants of erythema migrans are rare,
although 1 prospective study reported vesiculobul-
lous changes of the central portion of the lesion in 8%
of patients.4
The recognition of erythema migrans is
sufficiently distinctive to allow clinical diagnosis
and treatment of Lyme disease. In fact, the visual
inspection of the skin lesion is the preferred means
of diagnosis as serologic testing is too insensitive in
the acute phase of the disease (the first 2 weeks of
infection) to be helpful diagnostically,5 with IgM
antibodies usually becoming positive 2 to 6 weeks
after exposure.6 This requires the physician to
be aware of the classic appearance of erythema
migrans as well as its multiple atypical variants,
including bullous Lyme.
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